Leuprolide dosing & administration
A powerful GnRH agonist that helps manage hormone-sensitive conditions by controlling hormone production.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Dosing
How much do I take?
Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.
Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.
1 mg
Frequency
Once daily
Duration
Ongoing
The original daily form is a 1 mg shot under the skin each day for advanced prostate cancer. It works but needs a shot every day, so most people now use the longer-acting depot instead [4].
Timing
Best time to take
Administer Leuprolide at the same time each day (or on the same day each week for weekly injections). Many users prefer morning or evening administration. Pick a time you'll remember consistently.
With food?
Leuprolide injections can be given regardless of meal timing. However, if GI effects occur, administering on an empty stomach or with a light meal may help reduce discomfort.
If stacking
Leuprolide should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting your dose
Increase if
- You've tolerated the current dose for the recommended period without significant side effects
- Therapeutic goals haven't been met at the current dose level
- Your healthcare provider recommends dose escalation based on your response
- Lab work or clinical assessments support a higher dose
Decrease if
- Side effects are bothersome or impacting daily life despite management strategies
- You experience any signs of an adverse reaction
- Lab results indicate the need for dose reduction
- Your healthcare provider recommends a lower dose based on your response
Signs of right dose
- Therapeutic goals being met with minimal side effects
- Stable and consistent response to treatment
- Lab values or clinical markers trending in the right direction
- Good tolerance with manageable or absent side effects
Administration
How do I use it?
Reconstitution
What you need
Injection
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
Storage
Before reconstitution
Store Leuprolide in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After reconstitution
Once reconstituted, Leuprolide should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation — discard the vial
Sample daily schedule
As prescribed (once daily)
As prescribed by your healthcare provider injection
Site: Subcutaneous injection (daily)—rotate sites if applicable
Maintain a consistent schedule for optimal results with Leuprolide. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Safety
Is it safe?
Side effects
Commonly reported: Hot flashes (very common in men), Decreased libido and erectile dysfunction, Injection site pain or swelling, Nausea, Fatigue, Mood changes or depression, Joint or muscle pain, Headaches, Dizziness, Thinning hair, Decreased bone density (osteoporosis with long-term use), QT prolongation (rare but serious cardiac effect), Tumor flare (temporary worsening of cancer symptoms in first weeks), Severe allergic reactions, Spinal cord compression risk in men with metastatic disease
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Leuprolide
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Leuprolide should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Flagged pairings
- Other GnRH agonists (would cause overdosing) — Use with caution—discuss with your healthcare provider.
- Certain medications that prolong QT interval — Use with caution—discuss with your healthcare provider.
- Avoid if taking medications that significantly interact with testosterone suppression — Use with caution—discuss with your healthcare provider.
Published research
What the studies show
Swayzer DV, Gerriets V · 2025
Leuprolide, a GnRH agonist nonapeptide, is essential for managing prostate cancer, endometriosis, uterine fibroids, and precocious puberty by suppressing sex hormones through pituitary desensitization. Over four decades of clinical use has proven its safety and efficacy as a cornerstone therapy for hormone-sensitive conditions.
Seong GS, Seo SW, Cho JY · 2022
Researchers developed advanced analytical methods showing that fatty acid conjugation with leuprolide significantly extends its half-life and improves pharmacokinetic properties. These modifications create longer-acting formulations, allowing patients to receive medication less frequently through depot injections.
National Institute of Diabetes and Digestive and Kidney Diseases (LiverTox) · 2018
GnRH agonists including leuprolide achieve profound androgen and estrogen suppression without causing clinically significant liver damage, making them safe for long-term androgen deprivation therapy in advanced prostate cancer and benign hormone-responsive conditions.
AbbVie / U.S. FDA · 2017
For palliative treatment of advanced prostate cancer, the recommended dose of daily leuprolide acetate is 1 mg administered as a single subcutaneous injection once daily.
AbbVie / U.S. FDA · 2025
LUPRON DEPOT for prostate cancer is given by intramuscular injection as a long-acting depot: 7.5 mg every month (1-month), 22.5 mg every 3 months, 30 mg every 4 months, or 45 mg every 6 months.
Head to head
Leuprolide compared
Want the full picture?
The complete Leuprolide research profile: mechanism of action, clinical studies, effectiveness timeline, and FAQ.